[8-K] Shattuck Labs, Inc. Reports Material Event

Rhea-AI Filing Summary

Shattuck Labs, Inc. furnished a press release reporting its financial results for the quarter ended June 30, 2025. The 8-K states the press release is provided as Exhibit 99.1 and clarifies that the information is furnished (not "filed") for purposes of Section 18 of the Exchange Act and is not incorporated by reference in other filings except by specific reference. The filing confirms the company trades as STTK on The Nasdaq Global Select Market and that it is designated as an emerging growth company.

The 8-K contains no financial figures or discussion of results within the form itself and provides an exhibit listing and signature by CEO Dr. Taylor Schreiber. No additional operational or transaction details are included in this report.

Insights

Financial Analyst

TL;DR Routine disclosure: the company furnished a press release with quarter-end results but included no figures in the 8-K itself.

The 8-K serves a procedural role: it notifies the market that a press release describing the quarter ended June 30, 2025 results exists and is furnished as Exhibit 99.1. The filing explicitly states the exhibit is furnished, not filed, limiting Section 18 liabilities and incorporation by reference. Because no revenue, earnings, guidance, or other financial metrics are included in this filing, there is no new quantitative information for valuation or modeling contained in the 8-K itself.

Corporate Governance Expert

TL;DR Compliance-focused disclosure: appropriate exhibit furnishing and CEO execution, with limited substantive content in the filing.

The report properly furnishes the press release as an exhibit and includes the required signature by the principal executive officer, demonstrating compliance with disclosure procedures. The filing also indicates emerging growth company status. From a governance perspective this is a standard, timely disclosure step; however, investors must review Exhibit 99.1 for material content since the 8-K itself contains no financial data or analysis.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

0001680367FALSE00016803672025-08-072025-08-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2025

Shattuck Labs, Inc.

(Exact name of registrant as specified in its charter)

Delaware			001-39593			81-2575858
(State or other jurisdiction of incorporation or organization)			(Commission File Number)			(I.R.S. Employer Identification Number)

500 W. 5th Street, Suite 1200

Austin, TX 78701

(Address of principal executive offices including zip code)

(512) 900-4690

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuance to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.0001 per share			STTK			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company			☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act			☐

Item 2.02 Results of Operations and Financial Condition.

On August 14, 2025, Shattuck Labs, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated herein shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

Exhibits

Exhibit Number						Description of Exhibit
99.1						Press release issued by Shattuck Labs, Inc. regarding its financial results for the quarter ended June 30, 2025, dated August 14, 2025.
104						The cover page from the Company’s Current Report on Form 8-K formatted in Inline XBRL.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			Shattuck Labs, Inc.
Date: August 14, 2025			By:			/s/ Dr. Taylor Schreiber
						Dr. Taylor Schreiber Chief Executive Officer (principal executive officer)

3